Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1234.60
-10.90 (-0.88%)
< Home < Back

Dr. Reddy's Lab - Quaterly Results

Date: 29-10-2021
The Revenue for the quarter ended  September 2021 of Rs. 38234.00 millions grew by 14.27 % from Rs. 33458.00 millions.The Net proft of the company remain more or less same to Rs. 4490.00  millions from Rs. 4810.00 millions ,decline by -6.65%.Operating profit surged to 8664.00 millions from the corresponding previous quarter of 8432.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 38234.00 33458.00 14.27 72569.00 65902.00 10.12 133491.00 118504.00 12.65
Other Income 1181.00 266.00 343.98 3043.00 6713.00 -54.67 8011.00 7432.00 7.79
PBIDT 8664.00 8432.00 2.75 16145.00 24166.00 -33.19 39379.00 36128.00 9.00
Interest 111.00 93.00 19.35 176.00 233.00 -24.46 467.00 478.00 -2.30
PBDT 8553.00 8339.00 2.57 15969.00 23933.00 -33.28 38912.00 35650.00 9.15
Depreciation 2066.00 2142.00 -3.55 4037.00 4119.00 -1.99 8350.00 7892.00 5.80
PBT 6487.00 6197.00 4.68 11932.00 19814.00 -39.78 30562.00 27758.00 10.10
TAX 1997.00 1387.00 43.98 3308.00 5502.00 -39.88 8698.00 -1619.00 -637.25
Deferred Tax 841.00 273.00 208.06 1168.00 1997.00 -41.51 3297.00 -6458.00 -151.05
PAT 4490.00 4810.00 -6.65 8624.00 14312.00 -39.74 21864.00 29377.00 -25.57
Equity 832.00 831.00 0.12 832.00 831.00 0.12 832.00 831.00 0.12
PBIDTM(%) 22.66 25.20 -10.08 22.25 36.67 -39.33 29.50 30.49 -3.24